Trial NCT02890368

View at ClinicalTrials.gov 
Org. Study IDs: TTI-621-02

Last trial update was posted on 2023-04-05

MeSH Interventions

Immune Checkpoint Inhibitors Immunoglobulin G Interferons Talimogene laherparepvec

MeSH Conditions

Breast Neoplasms Carcinoma Carcinoma, Merkel Cell Mycoses Mycosis Fungoides Sarcoma

Other Conditions

Breast Carcinoma Human Papillomavirus-Related Malignant Neoplasm Melanoma Merkel-cell Carcinoma Soft Tissue Sarcoma Solid Tumors Squamous Cell Carcinoma

Stopping Reasons

N/A

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID